Back to Grantham, Mayo, Van Otterloo & Co. LLC Grantham, Mayo, Van Otterloo & Co. LLC

GSKGSK
Showing 8 of 16 quarters

Position history for Grantham, Mayo, Van Otterloo & Co. LLCGrantham, Mayo, Van Otterloo & Co. LLC's holdings in GLAXOSMITHKLINE PLC-SPON ADR

Grantham, Mayo, Van Otterloo & Co. LLC holds 3.6M shares of GSK (GLAXOSMITHKLINE PLC-SPON ADR), worth $188.7M as of 2026-Q2. The position was increased (+2.2% shares). GSK represents 0.4% of Grantham, Mayo, Van Otterloo & Co. LLC's portfolio.

Current Value

$188.7M

Current Shares

3.6M

Total Value Change

+$37.1M

Total Shares Change

-107,527

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.6M
+2.2%
$188.7M0.4%$51.95
37
2026-Q1
Increased
3.5M
+0.9%
$194.4M0.5%$54.20
37
2025-Q4
Increased
3.5M
+35.7%
$171.1M0.4%$47.78
47
2025-Q3
Decreased
2.6M
-1.1%
$111M0.3%$41.68
0
2025-Q2
Increased
2.6M
+21.5%
$99.9M0.3%$36.68
43
2025-Q1
Decreased
2.1M
-48.5%
$82.9M0.3%$36.58
0
2024-Q4
Increased
4.2M
+12.1%
$140.5M0.5%$31.59
41
2024-Q3
Increased
3.7M
+17.9%
$151.5M0.5%$37.75
42

Other major holders of GSK: FMR LLC, DODGE & COX

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used